Icon profits up 17% to €86m

IRISH pharmaceutical services company and clinical trials specialist, Icon, has reported a 17% increase in full-year operating profit to $116 million (€86m) for last year.

Net revenue also rose by 3% to $888m.

Full-year diluted earnings per share amounted to $1.53, 18% growth on the previous year.